DOPPS estimates of patient life years attributable to modifiable hemodialysis practices in the United States
- PMID: 14732826
- DOI: 10.1159/000074938
DOPPS estimates of patient life years attributable to modifiable hemodialysis practices in the United States
Abstract
Data from the Dialysis Outcomes and Practice Patterns Study (DOPPS) allow estimation of the percentage of patients outside published hemodialysis guidelines and their associated mortality risk. We estimated the number of life years that could be gained from adherence to four of these guidelines and two other modifiable practices, i.e. dialysis dose, phosphate control, improved anemia, partial correction of serum albumin, reduced interdialytic weight gain and less use of catheters for vascular access. We extrapolated DOPPS data on these practices and guidelines to the US hemodialysis population for a 5-year projected period. Of the practices we examined, the highest relative risk of mortality was associated with having albumin <3.5 g/dl (relative risk=1.38, p<0.0001); 20.5% of the patients in the study fell outside the target range. The adjusted sum of the patient years attributable to all six practice patterns was 143,617; a more conservative estimate, modeling life years potentially gained by bringing half of all patients outside targets within them, is 69,367. The magnitude of potential savings in life years should encourage greater adherence to guidelines and practices that are significantly associated with better survival.
Copyright 2004 S. Karger AG, Basel
Similar articles
-
[DOPPS estimate of patient life years attributable to modifiable hemodialysis practices in Spain].Nefrologia. 2007;27(4):496-504. Nefrologia. 2007. PMID: 17944588 Spanish.
-
[DOPPS estimate of patient life years attributable to modifiable hemodialysis practices in France].Nephrol Ther. 2008 Jul;4(4):256-65. doi: 10.1016/j.nephro.2008.01.003. Epub 2008 Apr 15. Nephrol Ther. 2008. PMID: 18417439 French.
-
[DOPPS estimate of guideline impact on survival in hemodialysis in Italy].G Ital Nefrol. 2007 May-Jun;24(3):221-9. G Ital Nefrol. 2007. PMID: 17554734 Italian.
-
Hemodialysis vascular access training and practices are key to improved access outcomes.Am J Kidney Dis. 2010 Dec;56(6):1032-42. doi: 10.1053/j.ajkd.2010.08.010. Epub 2010 Oct 20. Am J Kidney Dis. 2010. PMID: 20961676 Review.
-
Hemodialysis therapy in the United States: what is the dose and does it matter?Am J Kidney Dis. 1994 Dec;24(6):974-80. doi: 10.1016/s0272-6386(12)81108-5. Am J Kidney Dis. 1994. PMID: 7985679 Review.
Cited by
-
Demands for vascular access in a renal dialysis unit: implications for a regional vascular unit.Ir J Med Sci. 2006 Jan-Mar;175(1):24-8. doi: 10.1007/BF03168995. Ir J Med Sci. 2006. PMID: 16615224
-
Comprehensive and personalized care of the hemodialysis patient in tassin, france: a model for the patient-centered medical home for subspecialty patients.ISRN Nephrol. 2012 Dec 22;2013:792732. doi: 10.5402/2013/792732. eCollection 2013. ISRN Nephrol. 2012. PMID: 24967230 Free PMC article. Review.
-
Mortality and health-related quality of life in prevalent dialysis patients: Comparison between 12-items and 36-items short-form health survey.Health Qual Life Outcomes. 2012 May 6;10:46. doi: 10.1186/1477-7525-10-46. Health Qual Life Outcomes. 2012. PMID: 22559816 Free PMC article.
-
Hypoalbuminaemia and One-Year Mortality in Haemodialysis Patients with Heart Failure: A Cohort Analysis.J Clin Med. 2021 Sep 29;10(19):4518. doi: 10.3390/jcm10194518. J Clin Med. 2021. PMID: 34640538 Free PMC article.
-
Real-world effectiveness of valsartan on hypertension and total cardiovascular risk: review and implications of a translational research program.Vasc Health Risk Manag. 2011;7:209-35. doi: 10.2147/VHRM.S9434. Epub 2011 Mar 31. Vasc Health Risk Manag. 2011. PMID: 21490947 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical